JP2023538871A5 - - Google Patents
Info
- Publication number
- JP2023538871A5 JP2023538871A5 JP2023510345A JP2023510345A JP2023538871A5 JP 2023538871 A5 JP2023538871 A5 JP 2023538871A5 JP 2023510345 A JP2023510345 A JP 2023510345A JP 2023510345 A JP2023510345 A JP 2023510345A JP 2023538871 A5 JP2023538871 A5 JP 2023538871A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- aaa
- amino acid
- aminoalkyl
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202070526 | 2020-08-12 | ||
| DKPA202070526 | 2020-08-12 | ||
| PCT/EP2021/072251 WO2022034062A1 (en) | 2020-08-12 | 2021-08-10 | Exendin-4 peptide analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538871A JP2023538871A (ja) | 2023-09-12 |
| JP2023538871A5 true JP2023538871A5 (enExample) | 2024-08-19 |
Family
ID=80246995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023510345A Pending JP2023538871A (ja) | 2020-08-12 | 2021-08-10 | エキセンジン－４ペプチド類似体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230303640A1 (enExample) |
| EP (1) | EP4196495A1 (enExample) |
| JP (1) | JP2023538871A (enExample) |
| CN (1) | CN116390938A (enExample) |
| AU (1) | AU2021324066A1 (enExample) |
| BR (1) | BR112023002608A2 (enExample) |
| CA (1) | CA3190959A1 (enExample) |
| WO (1) | WO2022034062A1 (enExample) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4356108A (en) | 1979-12-20 | 1982-10-26 | The Mead Corporation | Encapsulation process |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| AU757658B2 (en) | 1998-03-09 | 2003-02-27 | Zealand Pharma A/S | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| EP1076066A1 (en) * | 1999-07-12 | 2001-02-14 | Zealand Pharmaceuticals A/S | Peptides for lowering blood glucose levels |
| US6528486B1 (en) * | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
| MXPA04012497A (es) * | 2002-07-04 | 2005-07-14 | Zealand Pharma As | Glp-1 y metodos para tratar la diabetes. |
| ES2407107T3 (es) | 2005-08-26 | 2013-06-11 | Abbvie Inc. | Análogos de alfa-MSH terapéuticamente activos |
| CN101861333A (zh) * | 2007-11-16 | 2010-10-13 | 诺沃-诺迪斯克有限公司 | 包含glp-1肽或毒蜥外泌肽-4和基础胰岛素肽的药物组合物 |
| WO2012162547A2 (en) * | 2011-05-25 | 2012-11-29 | Amylin Pharmaceuticals, Inc. | Long duration dual hormone conjugates |
| WO2014060606A1 (en) | 2012-10-19 | 2014-04-24 | Txp Pharma Gmbh | Alpha- and gamma-msh analogues |
| HUE035803T2 (en) * | 2012-12-21 | 2018-05-28 | Sanofi Sa | Dual GLP1 / GIP or trigonal GLP1 / GIP / glucagon agonists |
| HUE052977T2 (hu) * | 2014-04-22 | 2021-06-28 | Txp Pharma Gmbh | Elágazó szénláncú aminosav-próbával rendelkezõ peptid analóg(ok) |
| AR110300A1 (es) * | 2016-12-02 | 2019-03-13 | Sanofi Sa | Compuestos como agonistas peptídicos trigonales de los receptores de glp1 / glucagón / gip |
-
2021
- 2021-08-10 BR BR112023002608A patent/BR112023002608A2/pt unknown
- 2021-08-10 JP JP2023510345A patent/JP2023538871A/ja active Pending
- 2021-08-10 WO PCT/EP2021/072251 patent/WO2022034062A1/en not_active Ceased
- 2021-08-10 CN CN202180069840.1A patent/CN116390938A/zh active Pending
- 2021-08-10 AU AU2021324066A patent/AU2021324066A1/en active Pending
- 2021-08-10 EP EP21766122.2A patent/EP4196495A1/en active Pending
- 2021-08-10 US US18/020,813 patent/US20230303640A1/en active Pending
- 2021-08-10 CA CA3190959A patent/CA3190959A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7739384B2 (ja) | グルカゴン及びｇｌｐ－１共アゴニスト化合物 | |
| RU2378285C2 (ru) | Гибридные полипептиды с селектируемыми свойствами | |
| KR102440323B1 (ko) | 인크레틴 유사체 및 그의 용도 | |
| AU2017216533B2 (en) | Improved peptide pharmaceuticals | |
| CA2733005C (en) | Truncated analogues of glucose-dependent insulinotropic polypeptide | |
| CA2732949C (en) | Analogues of glucose-dependent insulinotropic polypeptide | |
| CN101790538B (zh) | 胰高血糖素/glp-1受体共激动剂 | |
| CA2378431A1 (en) | Peptides that lower blood glucose levels | |
| CN113366014A (zh) | 经修饰的gip肽类似物 | |
| JP2007001987A5 (enExample) | ||
| KR20150131213A (ko) | 인슐린-인크레틴 접합체들 | |
| JP2011524420A5 (enExample) | ||
| TW201010729A (en) | GIP-based mixed agonists for treatment of metabolic disorders and obesity | |
| CN108271356A (zh) | 肠降血糖素-胰岛素缀合物 | |
| IL277483B1 (en) | New anti-GLP-1 analogs | |
| CN103596973A (zh) | 多肽 | |
| EP3212217A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| US11572399B2 (en) | Long-acting GIP peptide analogues | |
| CN116854804A (zh) | 酰化胃泌酸调节素肽类似物 | |
| KR20230146040A (ko) | 글루카곤 유사 펩타이드-1 수용체 길항물질 | |
| US20240058422A1 (en) | Glucagon-like peptide-1 receptor antagonists | |
| KR20200044909A (ko) | 알부민과의 결합 친화성이 증대된 약학 구조물 | |
| EP1711523A1 (en) | Analogues of glp-1 | |
| CN108676084B (zh) | 艾塞那肽的修饰物及其应用 | |
| WO2006045710A2 (en) | Insulin receptor binding peptides with non-insulin gene activation profiles and uses thereof |